Atezolizumab Plus R-CHOP Deemed Unworthy of Additional Study in Diffuse Large B-Cell Lymphoma
Cancer Therapy Advisor,
Adding atezolizumab to standard care may improve responses in patients with previously untreated diffuse large B-cell lymphoma (D…